Search Results for Amjevita

Showing 1 – 1

FDA Approves First Humira Biosimilar By Michael Mezher - Published 23 September 2016

The US Food and Drug Administration (FDA) on Friday announced it had approved Amgen's Amjevita (adalimumab-atto), the first biosimilar version of AbbVie's best-selling biologic Humira (adalimumab).

Categories: News, US, FDA, Biologics and biotechnology, Submission and registration

Tags: Humira, Amjevita, Biosimilar, adalimumab, adalimumab-atto